NATALIE WILGOREN: Open Payments
NPI 1316917347 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 9 payments from 8 companies in 2025. Trend: 2023 $919 · 2024 $1,411 · 2025 $1,078
Food & beverage: $1,078
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $244 |
| Neurocrine BioSciences, Inc. | 1 | $135 |
| Supernus Pharmaceuticals, Inc. | 1 | $124 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| ABBVIE INC. | 1 | $123 |
| Axsome Therapeutics, Inc. | 1 | $112 |
| Alkermes, Inc. | 1 | $108 |
| Teva Pharmaceuticals USA, Inc. | 1 | $107 |
Products named: CAPLYTA, INGREZZA, Qelbree, COBENFY, VRAYLAR, Auvelity, LYBALVI, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
